Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Debt Ratio (2016 - 2025)

Arrowhead Pharmaceuticals (ARWR) has disclosed Debt Ratio for 11 consecutive years, with 0.13 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio fell 68.65% year-over-year to 0.13, compared with a TTM value of 0.13 through Dec 2025, down 68.65%, and an annual FY2025 reading of 0.18, down 46.66% over the prior year.
  • Debt Ratio was 0.13 for Q4 2025 at Arrowhead Pharmaceuticals, down from 0.18 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.4 in Q4 2024 and bottomed at 0.13 in Q4 2025.